Clinical Trials Directory

Trials / Completed

CompletedNCT03118908

Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome

Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen and Smart B by Women With Climacteric Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
I.M. Sechenov First Moscow State Medical University · Academic / Other
Sex
Female
Age
42 Years – 60 Years
Healthy volunteers
Accepted

Summary

To evaluate effectiveness and safety of combined use of dietary supplements Amberen and Smart B by women with a typical (without complications) form of climacteric syndrome, with mild to moderate symptoms.

Detailed description

1. To evaluate effectiveness of combined use of dietary supplements Amberen and Smart B (vs placebo) by women with a typical (without complications) form of climacteric syndrome, with mild to moderate vegetative symptoms during perimenopause and menopause in regards to vasomotor, endocrine-metabolic, and neuro-psychological dysfunctions; 2. To evaluate safety of combined use of dietary supplements Amberen and Smart B (vs placebo) by women with a typical (without complications) form of climacteric syndrome, with mild to moderate vegetative symptoms during perimenopause and menopause, lasting no less than 1 year in regards to vasomotor, endocrine-metabolic, and neuro-psychological dysfunctions; 3. To develop recommendations for combined use of dietary supplements Amberen and Smart B for women with a typical (without complications) form of climacteric syndrome, with mild to moderate vegetative symptoms during perimenopause and menopause (menopausal for at least 1 year).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmberenAmberen is a succinate-based dietary supplement previously shown to help provide relief for common menopausal symptoms.
DIETARY_SUPPLEMENTSmart BSmart B contains vitamins B1, B2, B6, B9, B12 and sodium fumarate.
DIETARY_SUPPLEMENTPlaceboPlacebo capsules are identical to Amberen and Smart B capsules.

Timeline

Start date
2017-04-24
Primary completion
2017-10-10
Completion
2017-10-10
First posted
2017-04-18
Last updated
2017-10-20

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03118908. Inclusion in this directory is not an endorsement.